AbstergoAbstergo Industries, a multinational corporation, reported a successful year in genetic research in 2023, aiming for further developments in 2024. Specializing in the study and application of genetic data, Abstergo has made breakthroughs in areas like disease cure development and genetic traits identification. For 2024, they plan to enhance their genetic memory exploring device, the Animus, and expand their global data network, Eye-Abstergo.
Abstergo Industries is dedicated to advancing the science of aging and developing treatments to slow the aging process. Aging is a complex process that involves a variety of biological pathways and mechanisms, including genetic, environmental, and lifestyle factors. Our research focuses on understanding these pathways and developing interventions that can target them to extend healthy […]
Abstergo Industries is proud to announce the latest iteration of the Animus, the revolutionary device that allows our researchers to experience the genetic memories of our test subject’s ancestors. The Animus has been a key tool in our research into the field of genetic memory, and the new Animus represents a major step forward in […]
Over the past two years, we have made significant progress in a number of key areas and wanted to take a moment to update you on our recent activities. As a global leader in the pharmaceutical, finance, and technology sectors, it is our responsibility to stay attuned to global developments and adapt accordingly. In light […]
Abstergo Industries is looking for test subjects for a current project. The content of the project is the research of certain genetic memories of persons with Scandinavian descent. If you are interested in working with Abstergo, please answer the following survey and follow the instructions. Test subjects make a valuable contribution to improving the world […]
Abstergo